MINNEAPOLIS, Nov. 4 /PRNewswire-FirstCall/ -- Uroplasty, Inc. (Amex: UPI) announced today that it will present at the Rodman & Renshaw 10th Annual Healthcare Conference on Monday, November 10, 2008 at the New York Palace Hotel in New York City. Dave Kaysen, President and Chief Executive Officer and Medi Jiwani, Vice President and Chief Financial Officer will discuss the Company's business strategy and historical financial performance at 4:55 p.m. Eastern Time.
Attendance at the conference is by invitation only. A live audio webcast of Uroplasty's presentation may be accessed through the Company's website at http://www.uroplasty.com. An archived replay of the presentation will be available after the live presentation, and can also be accessed at http://www.uroplasty.com.
About Uroplasty, Inc.
Uroplasty, Inc., headquartered in Minnetonka, Minnesota, with
wholly-owned subsidiaries in The Netherlands and the United Kingdom, is a
medical device company that develops, manufactures and markets innovative
proprietary products for the treatment of voiding dysfunctions. Our primary
focus is the continued commercialization of our Urgent PC system, which we
believe is the only FDA-approved minimally invasive nerve stimulation
device designed for office-based treatment of urinary urgency, urinary
frequency and urge incontinence - symptoms often associated with overactive
bladder. We also offer Macroplastique(R) Implants, an injectable bulking
agent for the treatment of adult female stress urinary incontinence
primarily due to intrinsic sphincter deficiency. Please visit Uroplasty,
Inc. at http://www.uroplasty.com.
For Further Information:
David Kaysen, President and CEO, or
Medi Jiwani, Vice President, CFO, and Treasurer,
Dahlia Bailey (Investors)
Steve DiMattia/Chris Gale (Media)
|SOURCE Uroplasty, Inc.|
Copyright©2008 PR Newswire.
All rights reserved